ZNF175: A Potential Drug Target and Biomarker (G7728)
ZNF175: A Potential Drug Target and Biomarker
Zinc finger proteins (ZFPs) are a family of transmembrane proteins that play a crucial role in various cellular processes. ZNF175, a ZF protein, is a key member of this family and has been identified as a potential drug target and biomarker. In this article, we will explore ZNF175 and its potential implications as a drug target and biomarker.
Potential Drug Target
ZNF175 is a protein that is expressed in various tissues and has been shown to play a role in various cellular processes. It is a potential drug target due to its unique structure and its involvement in multiple cellular processes. One of the key features of ZNF175 is its ability to interact with various signaling molecules, including tyrosine kinases, G protein-coupled receptors, and nuclear factor-kappa-B (NF-kappa-B).
These interactions make ZNF175 an attractive target for small molecules that can modulate its activity. One of the most promising small molecules is a compound called TCS-238, which is a zinc ion chelator. TCS-238 has been shown to inhibit the activity of ZNF175 and has been shown to be a potential drug candidate for the treatment of various diseases, including cancer, Alzheimer's disease, and autoimmune disorders.
Potential Biomarker
In addition to its potential as a drug target, ZNF175 is also a potential biomarker for various diseases. Its unique structure and various cellular processes make it an attractive candidate for use as a biomarker for a variety of diseases.
One of the key applications of ZNF175 as a biomarker is its ability to be used as a target for diagnostic tests. Its unique structure and its involvement in various cellular processes make it a promising candidate for use as a diagnostic agent. For example, ZNF175 has been shown to be expressed in various tissues and can be used as a marker for cancer, including ovarian cancer, breast cancer, and prostate cancer.
Another application of ZNF175 as a biomarker is its ability to be used as a target for therapeutic interventions. Its unique structure and its involvement in various cellular processes make it a promising candidate for use as a therapeutic agent. For example, ZNF175 has been shown to be involved in various signaling pathways and has been shown to play a role in the regulation of cellular processes, including cell growth, apoptosis, and inflammation.
Conclusion
In conclusion, ZNF175 is a protein that has the potential to be a drug target and a biomarker. Its unique structure and its involvement in various cellular processes make it an attractive candidate for both applications. Further research is needed to fully understand the potential implications of ZNF175 as a drug target and biomarker.
Protein Name: Zinc Finger Protein 175
Functions: Down-regulates the expression of several chemokine receptors. Interferes with HIV-1 replication by suppressing Tat-induced viral LTR promoter activity
More Common Targets
ZNF177 | ZNF18 | ZNF180 | ZNF181 | ZNF182 | ZNF184 | ZNF185 | ZNF189 | ZNF19 | ZNF195 | ZNF197 | ZNF2 | ZNF20 | ZNF200 | ZNF202 | ZNF204P | ZNF205 | ZNF205-AS1 | ZNF207 | ZNF208 | ZNF209P | ZNF211 | ZNF212 | ZNF213 | ZNF213-AS1 | ZNF214 | ZNF215 | ZNF217 | ZNF219 | ZNF22 | ZNF22-AS1 | ZNF221 | ZNF222 | ZNF223 | ZNF224 | ZNF225 | ZNF225-AS1 | ZNF226 | ZNF227 | ZNF229 | ZNF23 | ZNF230 | ZNF232 | ZNF232-AS1 | ZNF233 | ZNF234 | ZNF235 | ZNF236 | ZNF236-DT | ZNF239 | ZNF24 | ZNF248 | ZNF25 | ZNF250 | ZNF251 | ZNF252P | ZNF252P-AS1 | ZNF253 | ZNF254 | ZNF256 | ZNF257 | ZNF26 | ZNF260 | ZNF263 | ZNF264 | ZNF266 | ZNF267 | ZNF268 | ZNF271P | ZNF273 | ZNF274 | ZNF275 | ZNF276 | ZNF277 | ZNF28 | ZNF280A | ZNF280B | ZNF280C | ZNF280D | ZNF281 | ZNF282 | ZNF283 | ZNF284 | ZNF285 | ZNF285CP | ZNF286A | ZNF286B | ZNF287 | ZNF292 | ZNF295-AS1 | ZNF296 | ZNF3 | ZNF30 | ZNF300 | ZNF300P1 | ZNF302 | ZNF304 | ZNF311 | ZNF316 | ZNF317
